Blue-Chip Dividend Stocks Shine Bright Amid Market Uncertainty

Three blue-chip dividend stocks stand out as strong buys right now: AbbVie (NYSE: ABBV), Realty Income (NYSE: O), and Procter & Gamble (NYSE: PG).

AbbVie, a healthcare giant, has staged a comeback after concerns about the impact of losing patent exclusivity for its flagship drug Humira. The company's anti-inflammatory drugs Skyrizi and Rinvoq have been successful, with sales topping $5.5 billion and $2.5 billion respectively last quarter.

Realty Income, a real estate investment trust (REIT), has an over three-decade track record of dividend growth and a current forward dividend yield of around 5.5%. While it prioritizes cash flow, the company's dividend strategy is not leaving it stretched too thin.

Procter & Gamble, with a 70-year track record of raising its payouts each year, is firmly within the Dividend Kings category. Despite a recent modest increase in dividends due to near-term headwinds, the company expects factors like higher raw materials and energy costs to have a drag on earnings growth.